Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A Systemic Inflammation Response Index Could be a Predictive Factor for mFOLFIRINOX in Metastatic Pancreatic Cancer.
Pancreas. 2019 May/Jun;48(5):e45-e47. doi: 10.1097/MPA.0000000000001294.
Pancreas. 2019.
PMID: 31090669
No abstract available.
A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer.
Pacheco-Barcia V, Mondéjar Solís R, France T, Asselah J, Donnay O, Zogopoulos G, Bouganim N, Guo K, Rogado J, Martin E, Alcindor T, Colomer R.
Pacheco-Barcia V, et al. Among authors: mondejar solis r.
Pancreatology. 2020 Mar;20(2):254-264. doi: 10.1016/j.pan.2019.12.010. Epub 2019 Dec 14.
Pancreatology. 2020.
PMID: 31866391
Item in Clipboard
Bevacizumab in Combination with Capecitabine plus Irinotecan as First-Line Therapy in Metastatic Colorectal Cancer: A Pooled Analysis of 2 Phase II Trials.
García Alfonso P, Muñoz Martin A, Alvarez Suarez S, Blanco Codeidido M, Mondejar Solis R, Tapia Rico G, López Martín P, Martin M.
García Alfonso P, et al. Among authors: mondejar solis r.
Onkologie. 2013;36(6):363-7. doi: 10.1159/000351240. Epub 2013 May 21.
Onkologie. 2013.
PMID: 23774151
Clinical Trial.
Item in Clipboard
Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study.
Feliu J, Jorge Fernández M, Macarulla T, Massuti B, Albero A, González González JF, Quintero-Aldana G, Delgado-Mingorance JI, Fernández Montes A, García Piernavieja C, Valladares-Ayerbes M, López Muñoz AM, Mondéjar Solís R, Vicente P, Casado Gonzalez E, González Cebrián I, López-Vivanco G.
Feliu J, et al. Among authors: mondejar solis r.
Cancer Chemother Pharmacol. 2021 Apr;87(4):543-553. doi: 10.1007/s00280-020-04214-w. Epub 2021 Jan 15.
Cancer Chemother Pharmacol. 2021.
PMID: 33452559
Clinical Trial.
Item in Clipboard
[(18)F-FDG PET/CT in the evaluation of patients suspected of paraneoplastic neurological syndrome].
García Vicente AM, Vega Caicedo CH, Mondéjar Solís R, de Ayala Fernández JÁ, Garrido Robles JA, Pena Pardo FJ, Muñoz Pasadas M, Del Saz Saucedo P, Jiménez Londoño GA, León Martín A, Soriano Castrejón Á.
García Vicente AM, et al. Among authors: mondejar solis r.
Rev Esp Med Nucl Imagen Mol. 2015 Jul-Aug;34(4):236-43. doi: 10.1016/j.remn.2015.02.006. Epub 2015 Apr 10.
Rev Esp Med Nucl Imagen Mol. 2015.
PMID: 25864422
Spanish.
Item in Clipboard
Cite
Cite